Erika Ortolan

5PUBLICATIONS
22CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)AllergyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 25, 2026
Utility of combined CD39/CD73/CD38 expression for the detection of malignant T cells in Sézary syndrome.

|Feb 25, 2025
The CD39/CD73/Adenosine and NAD/CD38/CD203a/CD73 Axis in Cutaneous T-Cell Lymphomas.

Liyun Lin, Gabriele Roccuzzo, Yuliya Yakymiv

|Aug 30, 2022
CD39/CD73 dysregulation and adenosine metabolism contribute to T-cell immunosuppression in patients with Sézary syndrome.

Yuliya Yakymiv, Sara Marchisio, Erika Ortolan

|Mar 07, 2022
CD38 Expression by Circulating and Skin-Infiltrating Lymphocytes from Sezary Syndrome Patients: A Flow Cytometry and Immunohistochemistry Study.

Pietro Quaglino, Mauro Novelli, Paolo Fava

|Feb 15, 2022
Sézary Syndrome: Different Erythroderma Morphological Features with Proposal for a Clinical Score System.

Gabriele Roccuzzo, Silvia Giordano, Gianluca Avallone

Pageof 1

Frequent Collaborators

5 joint publications

Ada Funaro

3 joint publications

Yuliya Yakymiv

2 joint publications

Pietro Quaglino

2 joint publications

Valentina Pala